We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
It’s no secret that 2022 has been a challenging time within the market. Geopolitical issues, stubborn COVID-19 uncertainties, and a hawkish pivot from the Federal Reserve have all been thorns in the market’s side year-to-date.
However, believe it or not, there have been plenty of stocks in 2022 snapping the overall bearish trend.
Three of the top S&P 500 performers in 2022 – Occidental Petroleum (OXY - Free Report) , Cardinal Health (CAH - Free Report) , and Hess Corp. (HES - Free Report) – have all delivered substantial gains to investors.
The chart below illustrates the year-to-date performance of all three stocks.
Image Source: Zacks Investment Research
As we can see, all three stocks have gone on a stellar run in 2022. Let’s take a closer look at each one.
Occidental Petroleum
Occidental Petroleum is an integrated oil and gas company with significant exploration and production exposure.
Like many stocks in the Zacks Oils and Energy sector, OXY’s growth trajectory is impossible to ignore; the company’s earnings are forecasted to soar nearly 280% year-over-year in its current fiscal year (FY22) paired with revenue growth of 42%.
Still, the growth is projected to cool off in FY23, with estimates calling for a 23% year-over-year drop in earnings and a 9.6% pullback in revenue. This is shown in the chart below.
Image Source: Zacks Investment Research
Further, the company generates solid cash; OXY reported free cash flow of $3.6 billion in its latest quarter, enough for a sizable 36% Y/Y increase.
Image Source: Zacks Investment Research
Cardinal Health Inc.
Cardinal Health is a nationwide drug distributor and provider of services to pharmacies, healthcare providers, and manufacturers.
Analysts have raised their earnings outlook for CAH’s current and next fiscal year as of late, helping land the stock into a Zacks Rank #2 (Buy).
Image Source: Zacks Investment Research
Undoubtedly a major positive, Cardinal Health belongs to the elite Dividend Aristocrat group; Dividend Aristocrats are classified as companies with at least 25 consecutive annual dividend increases.
CAH’s annual dividend currently yields roughly 2.5%, above its Zacks Medical sector by a fair margin.
Image Source: Zacks Investment Research
Hess Corp.
Hess is a globally integrated energy company engaging in the exploration, production, development, transportation, purchase, and sale of crude oil and natural gas liquids.
Hess has been on a strong earnings streak, exceeding earnings and revenue estimates in four consecutive quarters. Just in its latest release, the company narrowly beat earnings expectations and posted revenue 7.4% above expectations.
Image Source: Zacks Investment Research
HES does pay a dividend, currently yielding a modest 1.1%, below its Zacks Oils and Energy sector average by a fair margin. Still, the company’s 6.4% five-year annualized dividend growth rate helps pick up the slack.
Image Source: Zacks Investment Research
Bottom Line
Investors are more than aware of how harsh the market has been in 2022, with many stocks residing in the red year-to-date.
Still, all three stocks above – Occidental Petroleum (OXY - Free Report) , Cardinal Health (CAH - Free Report) , and Hess Corp. (HES - Free Report) – have all shaken off the market’s woes, becoming top S&P 500 performers in 2022.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Shutterstock
3 Top S&P 500 Performers of 2022
It’s no secret that 2022 has been a challenging time within the market. Geopolitical issues, stubborn COVID-19 uncertainties, and a hawkish pivot from the Federal Reserve have all been thorns in the market’s side year-to-date.
However, believe it or not, there have been plenty of stocks in 2022 snapping the overall bearish trend.
Three of the top S&P 500 performers in 2022 – Occidental Petroleum (OXY - Free Report) , Cardinal Health (CAH - Free Report) , and Hess Corp. (HES - Free Report) – have all delivered substantial gains to investors.
The chart below illustrates the year-to-date performance of all three stocks.
Image Source: Zacks Investment Research
As we can see, all three stocks have gone on a stellar run in 2022. Let’s take a closer look at each one.
Occidental Petroleum
Occidental Petroleum is an integrated oil and gas company with significant exploration and production exposure.
Like many stocks in the Zacks Oils and Energy sector, OXY’s growth trajectory is impossible to ignore; the company’s earnings are forecasted to soar nearly 280% year-over-year in its current fiscal year (FY22) paired with revenue growth of 42%.
Still, the growth is projected to cool off in FY23, with estimates calling for a 23% year-over-year drop in earnings and a 9.6% pullback in revenue. This is shown in the chart below.
Image Source: Zacks Investment Research
Further, the company generates solid cash; OXY reported free cash flow of $3.6 billion in its latest quarter, enough for a sizable 36% Y/Y increase.
Image Source: Zacks Investment Research
Cardinal Health Inc.
Cardinal Health is a nationwide drug distributor and provider of services to pharmacies, healthcare providers, and manufacturers.
Analysts have raised their earnings outlook for CAH’s current and next fiscal year as of late, helping land the stock into a Zacks Rank #2 (Buy).
Image Source: Zacks Investment Research
Undoubtedly a major positive, Cardinal Health belongs to the elite Dividend Aristocrat group; Dividend Aristocrats are classified as companies with at least 25 consecutive annual dividend increases.
CAH’s annual dividend currently yields roughly 2.5%, above its Zacks Medical sector by a fair margin.
Image Source: Zacks Investment Research
Hess Corp.
Hess is a globally integrated energy company engaging in the exploration, production, development, transportation, purchase, and sale of crude oil and natural gas liquids.
Hess has been on a strong earnings streak, exceeding earnings and revenue estimates in four consecutive quarters. Just in its latest release, the company narrowly beat earnings expectations and posted revenue 7.4% above expectations.
Image Source: Zacks Investment Research
HES does pay a dividend, currently yielding a modest 1.1%, below its Zacks Oils and Energy sector average by a fair margin. Still, the company’s 6.4% five-year annualized dividend growth rate helps pick up the slack.
Image Source: Zacks Investment Research
Bottom Line
Investors are more than aware of how harsh the market has been in 2022, with many stocks residing in the red year-to-date.
Still, all three stocks above – Occidental Petroleum (OXY - Free Report) , Cardinal Health (CAH - Free Report) , and Hess Corp. (HES - Free Report) – have all shaken off the market’s woes, becoming top S&P 500 performers in 2022.